Abstract
Co-infection of COVID-19 and other respiratory pathogens, including influenza virus family, has been of importance since the beginning of the recent pandemic. As the upcoming flu season arrives in countries with ongoing COVID-19 epidemic, the need for preventive policy actions becomes more critical. We present a joint compartmental SEIRS-SIRS model for the co-circulation of SARS-CoV-2 and influenza and discuss the characteristics of the model, such as the basic reproduction number (R0) and cases of death and recovery. We implemented the model using 2020 to early 2021 data derived from global healthcare organizations and studied the impact of interventions and policy actions such as vaccination, quarantine, and public education. The VENSIM simulation of the model resulted in R0 = 7.5, which is higher than what was reported for the COVID-19 pandemic. Vaccination against COVID-19 dramatically slowed its spread and the co-infection of both diseases significantly, while other types of interventions had a limited impact on the co-dynamics of the diseases given our assumptions. These findings can help provide guidance as to which preventive policies would be most effective at the time of concurrent epidemics, and contributes to the literature as a novel model to simulate and analyze the co-circulation of respiratory pathogens in a compartmental setting that can further be used to study the co-infection of COVID-19 or similar respiratory infections with other diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Not Applicable
Data Availability
The VENSIM simulation models used during the current study are available and can be found at https://github.com/Rey-Zafarnejad/A_Joint_Compartmental_Model_for_The_Coinfection_of_SARSCoV2_and_Influenza. Further details on the model and simulation can be provided upon request.
